Arthur L Rawlings, MD | |
1 Hospital Dr, Columbia, MO 65212-0001 | |
(573) 882-6500 | |
(573) 884-6024 |
Full Name | Arthur L Rawlings |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1 Hospital Dr, Columbia, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235339573 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 2009005468 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Arthur L Rawlings, MD Po Box 843966, Kansas City, MO 64184-3966 Ph: (573) 884-3300 | Arthur L Rawlings, MD 1 Hospital Dr, Columbia, MO 65212-0001 Ph: (573) 882-6500 |
News Archive
Zogenix, Inc. today announced that it has received the 2011 Drug Delivery Partnerships™ ("DDP") Innovation Award in the Industry Achievement category for SUMAVEL DosePro (sumatriptan injection) Needle-free Delivery System.
Cardiology informatics constitutes a complex and historically siloed environment. Yet, a new generation of solutions is going beyond just supporting individual service lines, and now more efficiently integrates and manages the diverse care area workflows of the cardiology enterprise.
Noting that "non-communicable diseases (NCDs) kill four times the number of people in low- and middle-income countries (LMICs) that they do in high-income countries," Benn Grover, a health communications specialist who manages policy for the National Forum for Heart Disease and Stroke Prevention, and Felicia Knaul, an associate professor at Harvard Medical School and director of the Harvard Global Equity Initiative, write in the Huffington Post Blog.
Data from interim analyses of a Phase III clinical study in patients with primary immune deficiency (PID) who received Baxter's HyQ were presented at the 26th meeting of the European Society for Immunodeficiencies (ESID) in Istanbul, Turkey. HyQ is an immune globulin (IG) therapy facilitated subcutaneously by recombinant human hyaluronidase, a dispersion and permeation enhancer.
Precision medicine has become the leading innovation of cancer treatment. Patients are routinely treated with drugs that are designed to target specific tumors and molecules.
› Verified 8 days ago
Olivia Louise Bolles, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Columbia, MO 65212 Phone: 573-882-4141 | |
Alice Lee, Surgery Medicare: Accepting Medicare Assignments Practice Location: One Hospital Dr, Columbia, MO 65212 Phone: 573-882-5609 Fax: 573-884-6054 | |
Ioan-andrei Scumpu, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Dr, Mchaney Hall 404, Dco75.00, Columbia, MO 65212 Phone: 573-884-2000 | |
Marc L Miller, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 115 Business Loop 70 W, Columbia, MO 65203 Phone: 573-882-8454 Fax: 573-884-6054 | |
Dr. Mary Carr, MD Surgery Medicare: Medicare Enrolled Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Brent W Miedema, MD Surgery Medicare: Medicare Enrolled Practice Location: 800 Hospital Dr # 617, Columbia, MO 65201 Phone: 573-814-6346 | |
Richard Smith, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1 Hospital Drive, Columbia, MO 65201 Phone: 573-884-4854 Fax: 573-884-6054 |